A Case of Hereditary Spherocytosis with Hemolytic Anemia due to Mycoplasma pneumonia

마이코플라즈마 폐렴에 의해 용혈성 빈혈이 발현된 유전성 구상 적혈구증 1례

  • Na, Hye-Yeon (Department of Pediatrics, College of Medicine, Hallym University) ;
  • Shin, Seon-Hee (Department of Pediatrics, College of Medicine, Hallym University) ;
  • Lee, Kyu-Man (Department of Laboratory Medicine, College of Medicine, Hallym University) ;
  • Kim, Kwang-Nam (Department of Pediatrics, College of Medicine, Hallym University)
  • 나혜연 (한림대학교 의과대학 소아과학교실) ;
  • 신선희 (한림대학교 의과대학 소아과학교실) ;
  • 이규만 (한림대학교 의과대학 진단검사의학교실) ;
  • 김광남 (한림대학교 의과대학 소아과학교실)
  • Received : 2009.08.07
  • Accepted : 2009.09.13
  • Published : 2009.12.25

Abstract

Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children, with a peak incidence at 5-14 years. Extrapulmonary manifestations occur in 20-25% of patients with M. pneumoniae infection. Most auto-antibodies that cause immune hemolytic anemia in humans are cold agglutinins. The formation of cold agglutinins is frequently observed during M. pneumoniae infections, and cold agglutinin disease usually occurs during M. pneumoniae infections. Nevertheless, severe hemolysis is exceptional. If a patient has any underlying disease related to hemolysis, it is possible to accelerate hemolysis. Hereditary spherocytosis is a common cause of hereditary hemolytic anemia resulting from red blood cell membrane defects. Hemolysis of red cells may result from corpuscular abnormalities or extracorpuscular abnormalities, such as immune or non-immune mechanisms. We report a case of hereditary spherocytosis associated with severe hemolytic anemia due to Mycoplasma pneumonia.

5-14세에 호발하는 마이코플라즈마 폐렴은 20-25%에서 폐외 증상을 일으키는 것으로 알려져 있으며 이 중 혈액계 질환에는 용혈성 빈혈, 혈소판 감소증, 혈구포식세포 증식증(hemophagocytosis) 등이 있다. 마이코플라즈마 폐렴에서의 냉항체에 의한 자가면역성 용혈로 용혈성 빈혈이 발생할 수 있으며, 이 때 항체의 역가와 용혈의 정도에 상관관계가 있을 수 있다. 저자들은 마이코플라즈마 폐렴에 의해 용혈성 빈혈이 발현된 유전성 구상 적혈구증 1례를 경험하였기에 보고하는 바이다.

Keywords

References

  1. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697-728. https://doi.org/10.1128/CMR.17.4.697-728.2004
  2. Daxbock F, Zedtwitz-Bievenstein K, Burgmann H, Granninger W. Severe hemolytic anemia and excessive leukocytosis masking Mycoplasma pneumonia. Ann Hematol 2001;80:180-2. https://doi.org/10.1007/s002770000250
  3. Segel GB. Hereditary Spherocytosis. In : Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Textbook of pediatrics. 18th ed. Philadelphia : WB Saunders Co,2007:2020-3.
  4. Eber S, Lux SE. Hereditary spherocytosis - defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 2004;41:118-41. https://doi.org/10.1053/j.seminhematol.2004.01.002
  5. Tse WT, Lux SE. Red blood cell membrane disorders. Br J Haematol 1999;104:2-13. https://doi.org/10.1111/j.1365-2141.1999.01130.x
  6. Hassoun H, Palek J. Hereditary spherocytosis : a review of the clinical and molecular aspects of the disease. Blood Rev 1996;10:129-47. https://doi.org/10.1016/S0268-960X(96)90021-1
  7. Gehrs BC, Friedberg RC. Autoimuune hemolytic anemia. Am J Hematol 2002;69:258-71. https://doi.org/10.1002/ajh.10062
  8. Ali NJ, Sillis M, Andrews BE, Jenkins PF, Harrison BD. The clinical spectrum and diagnosis of Mycoplasma pneumoniae infection. Q J Med 1986;58:241-51.
  9. Inaba H, Geiger TL, Lasater OE, Wang WC. A case of hemoglobn SC disease with cold agglutinin-induced hemolysis. Am J Hematol 2005;78:37-40. https://doi.org/10.1002/ajh.20244
  10. Fukuda MN, Fukuda M, Hakomori S. Cell surface modification by endo-beta-galactosidase. Change of blood group activities and release of oligosaccharides from glycoproteins and glycosphingolipids of human erythrocytes. J Biol Chem 1979;254:5458-65.
  11. Loomes LM, Uemura K, Childs RA, Paulson JC, Rogers GN, Scudder PR, et al. Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type. Nature 1984;307:560-3. https://doi.org/10.1038/307560a0
  12. Costea N, Yakulis VJ, Heller P. The mechanism of induction of cold agglutinins by Mycoplasma pneumoniae. J Immunol 1971;106:598-604.
  13. Feizi T, Loveless RW. Carbohydrate recognition by Mycoplasma pneumoniae and pathologic consequences. Am J Respir Crit Care Med 1996;154(4 Pt 2):S133-6. https://doi.org/10.1164/ajrccm/154.4_Pt_2.S133
  14. Palek J, Jarolim P. Clinical expression and laboratory detection of red blood cell membrane protein mutations. Semin Hematol 1993;30:249-83.
  15. Streichman S, Gescheidt Y. Cryohemolysis for the detection of hereditary spherocytosis : correlation studies with osmotic fragility and autohemolysis. Am J Hematol 1998;58:206-12. https://doi.org/10.1002/(SICI)1096-8652(199807)58:3<206::AID-AJH8>3.0.CO;2-V
  16. Jaffe CJ, Atkinson JP, Frank MM. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man. J Clin Invest 1976;58:942-9. https://doi.org/10.1172/JCI108547
  17. Cherry JD. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis 1993;17(Suppl 1):S47-51. https://doi.org/10.1093/clinids/17.Supplement_1.S47